Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 137-152 , March 2006

From cadaver harvested homograft valves to tissue-engineered valve conduits

References 

  1. Grunkemeier GL, Bodnar E. Comparison of structural valve failure among different “models” of homograft valves. J Heart Valve Dis. 1994;3:556–560
  2. Grunkemeier GL, Bodnar E. Comparative assessment of bioprosthesis durability in the aortic position. J Heart Valve Dis. 1991;6:534
  3. Gallegos RP, Nockel PJ, Rivard AL, Bianco RW. The current state of in vivo pre-clinical animal models for heart valve evaluation. J Heart Valve Dis. 2005;14:423–432
  4. Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439–465
  5. Hopkins RA. Cardiac reconstructions with allograft tissues. New York: Springer-Verlag; 2005;655 pages
  6. Mayer JE. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin Thorac Cardiovasc Surg. 1995;7:130–132
  7. Yacoub M, Rasmi NRH, Sundt TM, Lund Oea. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg. 1995;110:186–194
  8. Clarke DR. Presidential address: value, viability and valves. J Thorac Cardiovasc Surg. 2002;124(1):1–6
  9. Harken DW, Curtis LE. Heart surgery: legend and a long look. Am J Cardiol. 1967;9:393–400
  10. Gross L, Kugel MA. Topographic anatomy and histology of the valves in the human heart. Am J Pathol. 1931;7:445–473
  11. Walther T, Walther C, Falk V. Early clinical results after stentless mitral valve implantation and comparison with conventional valve repair or replacement. Circulation. 1999;100(19 Supplement):II78–II83
  12. Shinoka T, Ma PX, Shum-Tim D, et al. Tissue-engineered heart valves: autologous valve leaflet replacement study in a lamb model. Circulation. 1996;94:II-164–II-168
  13. Shinoka T, Shum-Tim D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg. 1998;115:536–546
  14. Stock U, Nagashima M, Khalil PN, et al. Tissue-engineered valve conduits in the pulmonary circulation. J Thorac Cardiovasc Surg. 2000;119:732–740
  15. Shum-Tim D, Stock U, Harkach J, et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg. 1999;68:2298–2304
  16. Hoerstrup SP, Sodian R, Daebritz S, et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(suppl):III-44–III-49
  17. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 2000;6:75–79
  18. Shinoka T, Shum-Tim D, Ma PX, et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome?. Circulation. 1997;96:II 102–II 107
  19. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: a biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg. 1995;60:S353–S358
  20. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg. 2001;71:S428–S432
  21. O'Brien M, Goldstein S, Walsh S. The Synergraft recellularization: first studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999;13:87–92
  22. Elkins RC, Goldstein S, Hewitt CW, et al. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg. 2001;13:87–92
  23. Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation. 2000;102:III-50–III-55
  24. Booth C, Korossis SA, Wilcox HE. Tissue engineering of cardiac valve prostheses: I. Development and histologic characterization of an acellular scaffold. J Heart Valve Dis. 2002;11:457–462
  25. Korossis SA, Booth C, Wilcox HE. Tissue engineering of cardiac valve prostheses: II. Biomechanical characterization of decellularized porcine valves. J Heart Valve Dis. 2002;11:463–471
  26. Jockenhoevel S, Zund G, Hoerstrup SP. Fibrin gel—advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg. 2001;19:424–430
  27. Sakai T, Li RK, Weisel RD, et al. The fate of tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. J Thorac Cardiovasc Surg. 2001;121:932–942
  28. Shi Y, Ramanurthi A, Vesley I. Towards tissue engineering of a composite aortic valve. Biomed Sci Instrum. 2002;38:35–40
  29. Hoerstrup SP, Kadner A, Breymann C, Morris C. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg. 2002;74:46–52
  30. Sacks MA, He A, Baijens L, et al. Surface strains in the anterior leaflet of the functioning mitral valve. Ann Biomed Eng. 2002;30(10):1281–1290
  31. Merryman WD, YounI HD, Lukoff H, et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis”, AJP. Heart Circ Physiol. 2006 (January);290:
  32. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004;24:1–6
  33. Xing Y, He Z, Warnock JN, Hilbert SL, Yoganathan AP. Effects of constant static pressure on the biological properties of porcine aortic valve leaflets. Ann Biomed Eng. 2004;32(4):555–562
  34. Rabkin E, Padera RF, Schoen FJ. Phenotypic modulation of interstitial cells of human cardiac semilunar valves from fetal through adult life. In: Third Biennial Meeting of the Society for Heart Valve Disease, Vancouver. 2005;
  35. Hilbert S, Yanagida R, Linthurst-Jones A, et al. Decellularized allograft valve conduits used for RVOT reconstructions in juvenile sheep: valve function and explant pathology findings. In: Proceedings of the Eighth Annual Georgia Institute of Technology Workshop: Cardiovascular Tissue Engineering from Basic Biology to Cell-Based Therapies, Hilton Head, S.C.. 2004 (March);
  36. Hilbert SL, Yanagida R, Souza J, et al. Prototype anionic detergent technique used to decellularized allograft valve conduits evaluated in the right ventricular outflow tract in sheep. J Heart Valve Dis. 2004;13:831–840
  37. Ketchedjian A, Krueger P, Lukoff H, et al. Ovine panel reactive antibody assay of HLA response to allograft bioengineered vascular scaffolds. J Thorac Cardiovasc Surg. 2005;129:159–166
  38. Ketchedjian A, Linthurst-Jones A, Krueger P, et al. Recellularization of decellularized allograft scaffolds in ovine great vessel reconstructions. Ann Thorac Surg. 2005;79:888–896
  39. Hayward IP, Bridle KR, Campbell GR. Effect of extracellular matrix proteins on vascular smooth muscle cell phenotype. Cell Biol Int. 1995;19:727–734
  40. Weston MW, Yoganathan AP. Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Biomed Eng. 2001;29:752–763
  41. Vouyouka AG, Powell RJ, Ricotta J. Ambient pulsatile pressure modulates endothelial cell proliferation. J Mol Cell Cardiol. 1998;30:609–615
  42. Predel HG, Yang Z, von Segesser . Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet. 1992;340:878–879
  43. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 1993;120:577–585
  44. Salwen SA, Szarowski DH, Turner JN. Three-dimensional changes of the cytoskeleton of vascular endothelial cells exposed to sustained hydrostatic pressure. Med Biol Eng Comput. 1998;36:520–527
  45. Vandenburgh HH. Mechanical forces and their second messengers in stimulating cell growth in vitro. Am J Physiol. 1992;262(3 pt. 2):R350–R355
  46. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 2000;6:75–79
  47. Messier R, Bass B, Aly H, et al. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res. 1994;57:1–21
  48. Hoffman-Kim D, Maish M, Krueger P, et al. Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. Tissue Eng. 2005 (Jan–Feb);11(1–2):288–301
  49. Hopkins RA. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds. Invited Editorial. Circulation. 2005;111:2712–2714
  50. Rajani B, Uree RB, Ratliff NB. Evidence for rejection of homograft valves in infants. J Thorac Cardiovasc Surg. 1998;115:111–117
  51. Vogt P, Stallmach T, Niederhauser U, et al. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults. EJCTS. 1999;15:639–645
  52. Shaddy RE, Thompson DD, Osborne KA, Hawkins JAFT. Persistence of human leukocyte antigen (HLA) immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Am J Cardiol. 1997;80:358–359
  53. Motomura N, Imakita M, Yutani C, Kitoh Y, Kawashima Y, Oka T. Histological change in cryopreserved rat aortic allograft. J Cardiovasc Pathol. 1995;36:53–60
  54. Neves JP, Gulbenkian S, Ramos T, Martins AP, Caldas MC, Mascarenhas R. Mechanisms underlying degeneration of cryopreserved vascular homografts. J Thorac Cardiovasc Surg. 1997;113:1014–1021
  55. Neves J, Monteiro C, Santos R. Histologic and genetic assessment of explanted allograft valves. Ann Thorac Surg. 1995;60:141–145
  56. Hoekstra FM, Witvliet M, Knoeep CY, et al. Immunogenic human leukocyte antigen Class II antigens on human cardiac valve induce specific antibodies. Ann Thorac Surg. 1998;66:2022–2026
  57. Wagner E, Roy R, Marois Y, Douville Y, Guidoin R. Fresh venous allografts in peripheral arterial reconstruction in dogs: effects of histocompatibility and of short-term immunosuppression with cyclosporine A and mycophenolate mofetil. J Thorac Cardiovasc Surg. 1995;110:1723–1744
  58. Hoekstra F, Knoop C, Vaessen L. Donor-specific immune response against human cardiac valve allografts. J Thorac Cardiovasc Surg. 1996 (Aug);112(2):281–286
  59. Hoekstra F, Knoop C, Jutte . Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant. 1994;13:1095–1098
  60. Hoekstra FM, Witvliet M, Knoop C. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant. 1997;16:570–572
  61. Wychulis AR, Kincaid OW, Wallace RB. Primary dissecting aneurysms of peripheral arteries. Mayo Clin Proc. 1969;44:804–810
  62. McLaughlin JS. The renegade fact. Ann Thorac Surg. 2002;73:1031
  63. Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg. 2000;73:438–443
  64. Shaddy RE, Hunter DD, Osborn KA. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation. 1994;94:1063–1067
  65. Holmes JH, Bloch RD, Hall RA, Carter YM, Karmy-Jones RC. Natural history of traumatic rupture of the thoracic aorta managed nonoperatively: a longitudinal analysis. Ann Thorac Surg. 2002;73:1149–1154
  66. Morishita K, Murakami G, Koshino T, et al. Aortic root remodeling operation: how do we tailor a tube graft. Ann Thorac Surg. 2000;73:1117–1121
  67. Kirali K, Mansuroglu D, Omeroglu SN, et al. Five-year experience in aortic root replacement with the flanged composite graft. Ann Thorac Surg. 2002;73:1130–1137
  68. Hogan PG, Brien O'M. Improving the allograft valve: does the immune response matter?. J Thorac Cardiovasc Surg. 2003;126:1251–1253
  69. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg. 1998;115:118–127
  70. Allaire E, Bruneval P, Mandet C, Becquemin JP, Michel JB. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery. 1997;122:73–81
  71. Ketchedjian A, Lukoff H, Krueger P, Hopkins RA. Human in vitro macrophage assay to identify the relative innate pro-inflammatory potential of bioengineered vascular constructs. In: Proceedings of the Ninth Annual Hilton Head Workshop: Engineering Tissues. 19:2005;p. 50
  72. Hopkins RA. Cardiac reconstructions with allograft valves. New York: Springer-Verlag; 1989;194 pages
  73. Breuer CK, Mettler BA, Anthony T, Sales VL, Schoen FJ, Mayer JE. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Tissue Eng. 2004;10(11/12):1725–1736
  74. Flanagan TC, Pandit A. Living artificial heart valve alternatives: a review. Eur Cell Mater. 2003;6:28–76
  75. Rieder E, Seebacher G, Kasimir MT, et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation. 2005 (May 31);111(21):2792–2797
  76. Oei FB, Stegmann AP, van der Ham F, Zondervan PE, Vaessen LM, Baan CC. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts. J Heart Valve Dis. 2002;11:315–325
  77. Hogan P, Duplock L, Green M, et al. Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg. 1996;112:126–127
  78. Hawkins JA, Hillman ND, Lambert LM, et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery; comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg. 2003;126:247–252
  79. Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve Synergraft in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002–1006
  80. Stock UA, Schenke-Layland K. Performance of decellularized xenogenic tissue in heart valve replacement. Biomaterials. 2006 (Jan);27(1):1–2
  81. Hilbert SL, Yanagida R, Souza J, et al. Prototype anionic detergent technique used to decellularized allograft valve conduits evaluated in the right ventricular outflow tract in sheep. J Heart Valve Dis. 2004;13:831–840
  82. Hopkins RA, Reyes A, Imperato DA. Ventricular outflow tract reconstructions with cryopreserved cardiac valve homografts: a single surgeon's 10-year experience. Ann Surg. 1996;223:544–553
  83. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg. 1993;105:934–942
  84. Aklog L, Carr-White GS, Birks EJ, Yacoub MH. Pulmonary autograft versus aortic homograft for aortic valve replacement: interim results from a prospective randomized trial. J Heart Valve Dis. 2000;9:76–89
  85. Wang A, Jaggers J, Ungerleider RM, Lim CS, Ryan T. Exercise echocardiographic comparison of pulmonary autograft and aortic homograft of replacements for aortic valve disease in adults. J Heart Valve Dis. 2003;12:202–208
  86. Laforest I, Dumesnil JG, Briand M, Cartier PC, Pibarot P. Hemodynamic performance at rest and during exercise after aortic valve replacement: comparison of pulmonary autografts versus aortic homografts. Circulation. 2002;106:157–162
  87. St. Louis J, Corcoran P, Rajan S, et al. Effects of warm ischemia following harvesting of allograft cardiac valves. EJCTS. 1991;5:458–464[discus]
  88. Messier RH, Domkowski PW, Aly HM, et al. High-energy phosphate depletion in leaflet matrix cells during processing of cryopreserved cardiac valves. J Surg Res. 1992;52(5):483–488
  89. Domkowski PW, Messier RH, Crescenzo DG, et al. Preimplantation alteration of adenine nucleotides in cryopreserved heart valves. Ann Thorac Surg. 1993;55:1–7
  90. Abd-Elfattah AS, Messier RH, Domkowski PW, Crescenzo DG, Wallace RB, Hopkins RA. Inhibition of adenosine deaminase and nucleoside transport: utility in a model of homograft cardiac valve preimplantation processing. J Thorac Cardiovasc Surg. 1993;105:1095–1105
  91. Crescenzo DG, Hilbert SL, Messier RH, et al. Human cryopreserved allografts: electron microscopic analysis of cellular injury. Ann Thorac Surg. 1993;55:25–31
  92. Murray G. Homologous aortic valve segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology. 1956;7:466–471
  93. Brockbank KGM, Dawson PE, Carpenter JF. Heart valve leaflet revitalization. Tissue Cell Rep. 1993;1:18–19
  94. VanDerKamp AWM, Visser WJ, van Dongan JM, Nauta J, Galjaard H. Preservation of aortic heart valves with maintenance of cell viability. J Surg Res. 1981;30:47
  95. O'Brien MF, Stafford G, Gardner M, et al. The viable cryopreserved allograft aortic valve. J Card Surg. 1987;2:153–167
  96. Messier R, Bass BL, Domkowski PW, Hopkins RA. Interstitial cellular matrix restoration of cardiac valves following cryopreserved. J Thorac Cardiovasc Surg. 1999;118:36–49
  97. Hilbert SL, Luna RE, Zhang J, et al. Allograft heart valves: the role of apoptosis-mediated cell loss. J Thorac Cardiovasc Surg. 1999;117:454–462
  98. Findley WN, Lai JS, Onaran K. Creep and relaxation of nonlinear viscoelastic materials. New York, NY: Dover; 1976;
  99. Hilbert SL, Barrick MK, Ferrans VJ. Porcine aortic valve bioprosthesis: a morphologic comparison of the effects of fixation pressure. J Biomed Mater Res. 1990;24:773–787
  100. Hilbert SL, Sword LC, Batachelder KC, Barrick MKFV. The simultaneous assessment of bioprosthetic heart valve biomechanical properties and collagen crimp length. J Biomed Mater Res. 1996;31:503–509
  101. Bechtel JF, Bartels C, Schmidtke C, Skibba W, Muller-Steinhardt M, Kluter H. Does histocompatibility affect homograft valve function after the Ross procedure?. Ann Thorac Surg. 2001 (Jun);71(6):2003–2007
  102. Rocnik EF, van der Veer E, Cao H, Hegele RA, Pickering JG. Functional linkage between the endoplasmic reticulum protein HSP-47 and procollagen expression in human vascular smooth muscle cells. J Biol Chem. 2002;277(41):38571–38578
  103. Tasab M, Batten MR, Bulleid NJ. Hsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagen. EMBO J. 2000;19:2204–2211
  104. Hopkins RA, Hammon JW, Smith PK, McHale PA, Anderson RW. Adaptation of the pulmonary circulation to acute and chronic high flow stress. Circulation. 1978;58(Suppl. II):81
  105. Hopkins RA, Hammon JW, Smith PK, McHale PA, Anderson RW. Response of the pulmonary circulation to chronic pulmonary venous hypertension. Circulation. 1978;58(Suppl. II):81
  106. Hopkins RA, Hammon JW, McHale PA, Smith PK, Anderson RW. Pulmonary vascular impedance analysis of adaptation to chronically elevated blood flow in the awake dog. Circ Res. 1979;45:267–274
  107. Hopkins RA, Hammon JW, McHale PA, Smith PK, Anderson RW. An analysis of the pulsatile hemodynamic responses of the pulmonary circulation to acute and chronic pulmonary venous hypertension in the awake dog. Circ Res. 1980;47:902–919
  108. Domkowski P, Cockerham J, Crescenzo D, et al. Pulmonary hydraulic impedance responses to hypoxia and hypercapnia in newborn pigs. J Appl Physiol. 1994;77:386–396
  109. Hopkins RA. Right ventricular outflow tract reconstructions—the role of valves in the viable allograft era. Ann Thorac Surg. 1988;45:593–594
  110. Hu J, Gilmer L, Hopkins RA, Wolfinbarger L. Effects of antibiotics on cellular viability in porcine heart valve tissue. Cardiovasc Res. 1989;23:960–964
  111. Hu J, Gilmer L, Hopkins RA, Wolfinbarger L. Assessment of cellular viability in cardiovascular tissue as studied with 3H-Proline and 3H-Inulin. Cardiovasc Res. 1990;24:528–531
  112. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH. Effect of HLA mismatching and antibody status on “homovital” aortic valve homograft performance. Thorac Surg. 1998;66:S212–S215
  113. Crescenzo D, Hilbert S, Barrick M, Messier R, Wallace R, Hopkins R. Donor heart valves: electron microscopic and morphometric assessment of cellular injury induced by warm ischemia and cryopreserved. J Thorac Cardiovasc Surg. 1992;103:253–258
  114. Dignan R, O'Brien M, Hogan P, Passage J, Stephens F, Thornton A. Influence of HLA matching and associated factors on aortic valve homograft function. J Heart Valve Dis. 2000;9:504–511
  115. Jones M, Eidbo EE, Hilbert SL, Ferrans VJ, Clark RE. Anticalcification treatments of bioprosthetic heart valves: in vivo studies in sheep. J Card Surg. 1989;4:69–73
  116. Gao ZB, Pandya S, Hosein N, Sacks MS, Hwang NHC. Bioprosthetic heart valve leaflet motion monitored by dual camera stereo photogrammetry. J Biomech. 2000;33:199–207
  117. Nielsen PMF, Hunter PJ, Smaill BH. Biaxial testing of membrane biomaterials: testing equipment and procedures. J Biomech Eng. 1991;113:300
  118. Gloeckner D, Billiar KL, Sacks MS. The bending behavior of fixed porcine aortic cusp. In: Proceedings of the Third World Congress of Biomechanics. Japan: Hokaiddo; 1998;
  119. Sacks MS, Billiar KL. Biaxial mechanical behavior of bioprosthetic heart cusps subjected to accelerated testing. In:  Gabbay S,  Frater RW editor. Advances in anticalcific and antidegenerative treatment of heart valve prostheses. Austin, TX: Silent Partners; 1997;
  120. Domkowski P, Cockerham J, Kot P, et al. Relationship of hydraulic impedance, elasticity, and geometry in the pulmonary artery of maturing newborn pigs. J Surg Res. 2001;100:116–126
  121. Maish M, Hoffman-Kim D, Krueger PM, Souza JM, Harper JJ, Hopkins RA. Tricuspid valve biopsy—a potential source of cardiac myofibroblast cells for tissue engineered cardiac valves. J Heart Valve Dis. 2003;12:264–269
  122. Billiar KL, Sacks MS. Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp: Part I. Experimental results. J Biomech Eng. 2000;122:23–30
  123. Sacks MS. Biaxial mechanical evaluation of planar biological materials. J Elast. 2000;61:199–246
  124. Takemura H, Yamamoto H, Kunishima H, et al. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila. J Antimicrob Chemother. 2000;46:589–594
  125. Xing Y, He Z, Warnock JN, Hilbert SL, Yoganathan AP. Effects of constant static pressure on the biological properties of porcine aortic valve leaflets. Ann Biomed Eng. 2004;32:555–562
  126. Xing Y, Warnock JN, He Z, Hilbert SL, Yoganathan AJ. Cyclic pressure affects the biological properties of porcine aortic valve leaflets in a magnitude and frequency dependent manner. Ann Biomed Eng. 2004;32:1461–1470
  127. Lipke DW, Couchman JR. Increased proteoglycan synthesis by cardiovascular system of coarctation hypertensive rats. J Cell Physiol. 1991;147:479–486
  128. Willems IE, Havenith J, Mits JF, Daemen MJ. Structural alterations in heart valves during left ventricular pressure overload in the rat. Lab Invest. 1994;71:127–133
  129. Quick DW, Kunzelman S, Kneebone JM, Cochran RP. Collagen synthesis is upregulated in mitral valves subjected to altered stress. ASAIO J. 1997;43:181–186
  130. Butcher JT, Penrod AM, Garcia AJ, Nerem RM. Unique morphology and focal adhesion development of valvular endothelial in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004 (Aug);24(8):1429–1434
  131. Ara Ketchedjian, George Cooper, Steve Hilbert, et al. “Chronic sheep implant study of small intestinal submucosa: fabricated pulmonary and mitral valve replacements” presented at American College of Surgeons October, 2004.
  132. Messier R, Domkowski P, Aly H, et al. Adenine nucleotide depletion in cryopreserved human cardiac valves: the ‘stunned’ leaflet interstitial cell population. Cryopreserved Biol. 1995;32:199–208
  133. Schenke-Layladm k, Riemann I, Optiz F, Konig K, Halbhuber KJ, Stock UA. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol. 2004;23:113–125
  134. Roy A, Brand NJ, Yacoub MH. Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves. J Heart Valve Dis. 2000;9:256–260
  135. Roy A, Brand NJ, Yacoub MH. Molecular characterization of interstitial cells isolated from human heart valves. J Heart Valve Dis. 2000;9:459–464
  136. Salwen S, Szarowski DH, Turner JN, Bizios R. Three-dimensional changes of cytoskeleton of vascular endothelial cells exposed to sustained hydrostatic pressure. Med Biol Eng Comput. 1998;36:520–527
  137. Schneider PJ, Deck JD. Tissue and cell renewal in the natural aortic valve of rats: an autoradiographic study. Cardiovasc Res. 1981;15:181–189
  138. Katwa LC, Tyagi SE, Campbell DJ, Lee G, Cicila GT, Weber KT. Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides. Int J Biochem Cell Biol. 1996;28:807–821
  139. Dreger SA, Taylor PM, Allen SP, Yacoub MH. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J Heart Valve Dis. 2002;11:875–880
  140. Sacks MS, Schoen FJ. Collagen fiber distribution occurs independent of calcification in clinically explanted bioprosthetic heart valves. Biomed Mater Res. 2002 (Dec 5);62(3):359–371
  141. Billiar KL, Sacks MS. Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp: Part I. Experimental results. J Biomech Eng. 2000;122:23–30
  142. Billiar KL, Sacks MS. Biaxial mechanical properties of the native and glutaraldehyde-treated aortic valve cusp: Part II. A structural constitutive model. J Biomech Eng. 2000;122:327–335
  143. Wells SM, Sacks MS. Effects of fixation pressure on the biaxial mechanical behavior of porcine bioprosthetic heart valves with long-term cyclic loading. Biomaterials. 2002;23:2389–2399
  144. Sacks MS, Gloeckner DC, Vyanvahare N, Levy RJ. Alterations in the flexural behavior of porcine bioprosthetic heart valves with fatigue. J Heart Valve Dis (submitted for publication).
  145. Sacks MS, Chuong CJ. Orthotropic mechanical properties of chemically treated bovine pericardium. Ann Biomed Eng. 1998;26:892–902
  146. Engelmayer GC, Hildebrand DK, Sutherland WH, Mayer JE, Sacks MS. Novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials. 2003 (Jun);24(14):2523–2532
  147. Hildebrand DK. A novel testing system for fatigue studies of heart valve biomaterials. Annals of Biomedical Engineering (submitted for publication).
  148. Eliktar D, Nerem RM, Galis ZS. The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain. J Biomech Eng. 2001;29:923–934
  149. Levesque MJ, Nerem RM. The elongation and orientation of cultured endothelial cells in response to shear stress. J Biomech Eng. 1985;107:341–347
  150. Weston MW, Yoganathan A. Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann Biomed Eng. 2001;29:752–763
  151. Simon P, Kasimir MT, Seebacker G, et al. Early failure of the tissue engineered porcine heart valve Synergraft in pediatric patients. Eur J Cardiothorac Surg. 2003 (Jun);23(6):1002–1006
  152. Lu Y, Shansky J, Del Tatto M, et al. Therapeutic potential of implanted tissue-engineered bioartificial muscles delivering recombinant proteins to the sheep heart. Ann N Y Acad Sci. 2002;961:78–82
  153. Filip DA, Radu A, Simionescu M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res. 1986;59:310–319
  154. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation. 2002;104:2525–2532
  155. Bernacca GM, Gibson SA, Wilkenson R, Wheatley DJ. Confocal laser scanning microscopy of calcified bioprosthetic heart valves. J Heart Valve Dis. 1994;3:205–211
  156. Hoerstrup SP, Zünd G, Ye Q, Schoeberlein A, Schmid AC, Turina M. Tissue engineering of a bioprosthetic heart valve: stimulation of extracellular matrix assessed by hydroxyproline assay. ASAIO J. 1999;45:397–402
  157. Hong T, Maish MS, Cohen J, et al. Reproducible echocardiography in juvenile sheep and its application in the evaluation of a pulmonary valve allograft implant. Contem Top Lab Anim Sci. 2000;39:15–21
  158. Piatosa B, Birbach M, Fedorowicz M, Maruszewski B. Presence of IgG anti-HLA antibodies in fourteen patients after cryopreserved allogenic heart valve implantation. Transplant Proc. 2002;34:643–644
  159. Magid R, Murphy TJ, Galis ZS. Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of C-Myc. J Biol Chem. 2003 (Aug);29;278(35):32994–32999
  160. Merryman WD, Youn HDI, Lukoff H, et al. “Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis”, AJP: Heart and Circulatory Physiology, 290: (January); 2006.
  161. Koolbergen Dr, Hazekamp MG, de Heer E, Bruggemans EF, Huysmans HA, Dion RA. The pathology of fresh and cryopreserved heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg. 2002;124:689–697
  162. Gibbon JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171–174
  163. Zehr KJ, Yagubyan M, Connolly HM, Nelson SM, Schaff HV. Aortic root replacement with a novel decellularized aortic homograft: postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg. 2005;130:1010–1015
  164. Rhim C, Niklason LE. Tissue engineered vessels: cells to telomeres. Prog Pediatr Cardiol. 2005;
  165. Fong P, Shinʼoka T, Lopez-Soler RI, Breuer C. The use of polymer based scaffolds in tissue-engineered heart valves. Prog Pediatr Cardiol. 2005;
  166. Taylor PM, Cass AEG, Yacoub MH. Extracellular matrix scaffolds for tissue engineering heart valves. Prog Pediatr Cardiol. 2005;
  167. Merryman WD, Engelmayr GC, Liao J, Sacks MS. Defining biomechanical endpoints for tissue engineered heart valve leaflets from native leaflet properties. Prog Pediatr Cardiol. 2005;
  168. Christenson JT, Kalangos A. Blood group antigenicity and clinical durability of cryopreserved homografts. Prog Pediatr Cardiol. 2005;
  169. Simon P, Kasimir M-T, Rieder E, Weigel G. Tissue engineering of heart valves—immunologic and inflammatory challenges of the allograft scaffold. Prog Pediatr Cardiol. 2005;
  170. Johnson TL, Barabino GA, Nerem RM. Engineering more physiologic in vitro models for the study of vascular biology. Prog Pediatr Cardiol. 2005;
  171. Baldwin JT, Duncan BW. Ventricular assist devices for children. Prog Pediatr Cardiol. 2005;
  172. Vandenburgh HH. Bioengineered muscle constructs and tissue-based therapy for cardiac disease. Prog Pediatr Cardiol. 2005;

PII: S1058-9813(05)00079-2

doi: 10.1016/j.ppedcard.2005.11.002

Progress in Pediatric Cardiology
Volume 21, Issue 2 , Pages 137-152 , March 2006

Article Tools

* Image Usage & Resolution